Neuroblastoma: estrategias mecanoterapéuticas basadas en modelos 3D y tumores derivados de pacientes con microambiente rico en vitronectina
Datos básicos
- Protocolo:
- PI20/01107
- EUDRACT:
- NCT:
- Centro:
- UNIVERSIDAD DE VALENCIA
- Año de incio:
- 2021
- Año de finalización:
- 2024
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
Resultados del Ensayo Clínico
Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines.
López-Carrasco, A; (...); Noguera, R
Article. 10.3390/cancers16193347. 2024
Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.
Sanegre, S; (...); Noguera, R
Article. 10.3389/fcell.2021.670185. 2021
Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma
Stoks, M; (...); Noguera, R
Article. 10.1016/j.compbiomed.2023.107364. 2023
Immunometabolism Modulation in Therapy.
Monferrer, E; (...); Naranjo, TA
Article. 10.3390/biomedicines9070798. 2021
Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study.
Corallo, Diana; (...); Aveic, Sanja
Article. 10.3390/cells10102695. 2021
Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma.
Lopez-Carrasco, Amparo; (...); Noguera, Rosa
Article. 10.3390/cancers13205173. 2021
Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction.
Monferrer, Ezequiel; (...); Alvaro Naranjo, Tomas
Article. 10.3390/metabo11050264. 2021
Real-time morphometric analysis of targeted therapy for neuroblastoma cells in monolayer and 3D hydrogels using digital holographic microscopy.
Granados-Aparici, S; (...); Noguera, R
Article. 10.1016/j.isci.2024.111231. 2024
Risk of developing neuroblastoma influenced by maternal stressful life events during pregnancy and congenital pathologies
Benavent N; (...); Tadeo I
Article. 10.1002/pbc.31402. 2025
The complexity of cancer immunotherapy illustrated through skin tumors.
Vieco-Marti, I; (...); Alvaro Naranjo, T
Article. 10.1177/03936155221088884. 2022
The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models.
Masanas, Marc; (...); Segura, Miguel F
Letter. 10.1002/ctm2.533. 2021
Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma.
Burgos-Panadero, Rebeca; (...); Noguera, Rosa
Article. 10.1016/j.ijpharm.2021.121058. 2021
Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?
López-Carrasco A; (...); Noguera R
Article. 10.3390/ijms25168733. 2024